Fallopian Tube

Oncology

29 drugs in development·8 companies·1 clinical trial

Drug Pipeline by Phase

Approved(3)

Phase 3(12)

Drug	Company
AZD5335	ASTRAZENECA PLC (AZN)
Background Chemotherapy	Merus N.V. (MRUS)
Ceralasertib	ADMA BIOLOGICS, INC. (ADMA)
Ceralasertib	Relay Therapeutics, Inc. (RLAY)
First-line Chemotherapy	Merus N.V. (MRUS)
Hyperthermic Intraperitoneal Chemotherapy	Merus N.V. (MRUS)
Investigator's selection of appropriate chemotherapy regimen	Merus N.V. (MRUS)
Lymphodepleting chemotherapy	Merus N.V. (MRUS)
Physician's choice chemotherapy	Merus N.V. (MRUS)
Rescue medications for chemotherapy	Merus N.V. (MRUS)
Single-agent chemotherapy	Merus N.V. (MRUS)
timing to initiate the adjuvant FOLFOX chemotherapy	Merus N.V. (MRUS)

Phase 2(2)

Drug	Company
Adavosertib	ADMA BIOLOGICS, INC. (ADMA)
Olaparib	ADMA BIOLOGICS, INC. (ADMA)

Phase 1(2)

Drug	Company
Birinapant	IGM Biosciences, Inc. (IGMS)
imgn151	ImmunoGen, Inc. (IMGN)

Phase 1/Phase 2(1)

Drug	Company
Itraconazole	ASTRAZENECA PLC (AZN)

Phase 4(9)

Drug	Company
CAPOX chemotherapy	Merus N.V. (MRUS)
Chemotherapy Regimen	Merus N.V. (MRUS)
Concurrent chemotherapy	Merus N.V. (MRUS)
Conditioning chemotherapy	Merus N.V. (MRUS)
FOLFOX chemotherapy	Merus N.V. (MRUS)
Lymphodepletion Chemotherapy	Merus N.V. (MRUS)
Platinum chemotherapy	Merus N.V. (MRUS)
Single Cycle Intensive Chemotherapy	Merus N.V. (MRUS)
Tandem 3 Cycle Intensive Chemotherapy	Merus N.V. (MRUS)

BioSniper tracks 29 drugs in development for Fallopian Tube across 8 companies.

There are 1 clinical trial targeting Fallopian Tube tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.